NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,930 Cr | ₹2,180 Cr | ₹1,833 Cr | ₹1,580 Cr | ₹1,383 Cr |
What is the latest Total Liabilities ratio of NEULAND LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹2,930 Cr |
| Mar2025 | ₹2,180 Cr |
| Mar2024 | ₹1,833 Cr |
| Mar2023 | ₹1,580 Cr |
| Mar2022 | ₹1,383 Cr |
How is Total Liabilities of NEULAND LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,930 Cr | 34.42 | |
| Mar2025 | ₹2,180 Cr | 18.95 | |
| Mar2024 | ₹1,833 Cr | 16.00 | |
| Mar2023 | ₹1,580 Cr | 14.19 | |
| Mar2022 | ₹1,383 Cr | - | |
Compare Total Liabilities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹29,724.4 Cr | 1.7% | 21.7% | 75.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,479.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 1.7% |
21.7% |
75.8% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses